What is the purpose of the sequence rules in patent applications?

What is the purpose of the sequence rules in patent applications? The sequence rules in patent applications serve several important purposes, as explained in MPEP 2412.01: “The sequence rules […] set forth a standardized format for describing nucleotide and amino acid sequences in patent applications. This standardized format allows for the presentation of such sequences…

Read More

What is the purpose of the Sequence Listing Incorporation by Reference statement?

What is the purpose of the Sequence Listing Incorporation by Reference statement? The Sequence Listing Incorporation by Reference statement serves a crucial purpose in patent applications containing nucleotide and/or amino acid sequences. According to MPEP 2420: “The incorporation by reference statement must indicate that the sequence listing is part of the specification and must be…

Read More

What is the scope of the PTAB’s jurisdiction in a derivation proceeding?

The Patent Trial and Appeal Board (PTAB) exercises broad and exclusive jurisdiction over patent applications involved in derivation proceedings. According to MPEP 2313, which cites 37 CFR 42.3: “The Board may exercise exclusive jurisdiction within the Office over every involved application and patent during the proceeding, as the Board may order.” This means that the…

Read More

How does prosecution laches differ from statutory time limits in patent applications?

Prosecution laches is distinct from statutory time limits in patent applications. While statutory time limits are fixed by law, prosecution laches is a doctrine that addresses unreasonable and unexplained delays in prosecution. According to MPEP 2190: “While there are no firm guidelines for determining when laches is triggered, it applies only in egregious cases of…

Read More

How should sequence variants be presented in a patent application?

According to MPEP 2422.01, sequence variants in patent applications can be presented as follows: Present a single, primary sequence in the specification and “Sequence Listing” by enumeration of its residues. Discuss and/or claim variants of that primary sequence without presenting each variant as a separate sequence in the “Sequence Listing”. Annotate the primary sequence in…

Read More

What precautions should patent applicants take regarding admissions in their applications?

Patent applicants should be cautious when making statements in their applications to avoid unintentional admissions of prior art. Based on the guidance in MPEP 2129, here are some precautions applicants should take: Be precise in language: Avoid characterizing your own work or others’ work as “prior art” unless you intend it to be treated as…

Read More